Research progress of Hashimoto's thyroiditis

doi:10.3760/cma.j.issn.1007-1245.2023.06.001

International Medicine and Health Guidance News ›› 2023, Vol. 29 ›› Issue (6): 741-744.DOI: 10.3760/cma.j.issn.1007-1245.2023.06.001

• New Medical Advances • Next Articles

Research progress of Hashimoto's thyroiditis

Yao Wenjie¹, Song Kaiyu², Jiang Guantong³, Chen Xi¹, Zhou Jin²

¹Second Medical College, Binzhou Medical University, Yantai 264003, China; ²Department of Endocrinology, Yantai Yuhuangding Hospital, Yantai 264000, China; ³Department of Endocrinology, Yantai Haigang Hospital, Yantai 264000, China

Received:2022-11-23 Online:2023-03-15 Published:2023-04-02
Contact: Zhou Jin, Email: zhoujinsy@163.com
Supported by:
National Natural Science Foundation (81700695); Public Dispatch Project Supported by National Scholarship Fund (201909370036)

桥本甲状腺炎的研究进展

姚文杰¹ 宋凯雨² 姜冠桐³ 陈茜¹ 周瑾²

¹滨州医学院第二临床医学院，烟台　264003；²烟台毓璜顶医院内分泌科，烟台　264000；³烟台海港医院内分泌科，烟台　264000

通讯作者: 周瑾，Email：zhoujinsy@163.com
基金资助:
国家自然科学基金（81700695）；国家留学基金公派留学项目（201909370036）

Abstract

Abstract:

Hashimoto's thyroiditis is characterized by thyroid-specific autoantibodies and is one of the most common autoimmune diseases. In recent years, its prevalence is increasing dramatically and has gradually become a hot topic in the society. This literature review introduces the pathogenesis of Hashimoto's thyroiditis from three aspects: immune factors, autophagy, and apoptosis affecting the disease, hoping to gain a deeper understanding of the disease and to better guide clinical work.

Key words:

Hashimoto's thyroiditis, Immune factors, Autophagy, Apoptosis

摘要：

桥本甲状腺炎以甲状腺特异性自身抗体为特征，是最常见的自身免疫性疾病之一。近年来其患病率急剧增加，并逐渐成为社会所关注的热点话题。这篇文献综述从影响疾病的免疫因素、自噬及凋亡3个方面介绍了桥本甲状腺炎的发病机制，期望能够更深入了解该疾病，从而更好地指导临床工作。

关键词:

桥本甲状腺炎, 免疫因素, 自噬, 凋亡

Yao Wenjie, Song Kaiyu, Jiang Guantong, Chen Xi, Zhou Jin.

Research progress of Hashimoto's thyroiditis [J]. International Medicine and Health Guidance News, 2023, 29(6): 741-744.

姚文杰宋凯雨姜冠桐陈茜周瑾.

桥本甲状腺炎的研究进展 [J]. 国际医药卫生导报, 2023, 29(6): 741-744.

References

[1] Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria [J]. Autoimmun Rev, 2014, 13(4-5): 391-397. DOI: 10.1016/j.autrev.2014.01.007.
[2] Lillevang-Johansen M, Abrahamsen B, Jørgensen HL, et al. Duration of over- and under-treatment of hypothyroidism is associated with increased cardiovascular risk [J]. Eur J Endocrinol, 2019, 180(6): 407-416. DOI: 10.1530/EJE-19-0006.
[3] Hasham A, Tomer Y. Genetic and epigenetic mechanisms in thyroid autoimmunity [J]. Immunol Res, 2012, 54(1-3): 204-213. DOI: 10.1007/s12026-012-8302-x.
[4] Zhang QY, Ye XP, et al. Lymphocyte infiltration and thyrocyte destruction are driven by stromal and immune cell components in Hashimoto's thyroiditis [J]. Nat Commun, 2022, 13(1): 775. DOI: 10.1038/s41467-022-28120-2.
[5] Zheng H, Xu J, Chu Y, et al. A global regulatory network for dysregulated gene expression and abnormal metabolic signaling in immune cells in the microenvironment of Graves' disease and Hashimoto's thyroiditis [J]. Front Immunol, 2022,13:879824. DOI: 10.3389/fimmu.2022.879824.
[6] Tomari S, Watanabe M, Inoue N, et al. The polymorphisms in the thyroid peroxidase gene were associated with the development of autoimmune thyroid disease and the serum levels of anti-thyroid peroxidase antibody [J]. Endocr J, 2017, 64(10): 1025-1032. DOI: 10.1507/endocrj.EJ17-0191.
[7] Mizuma T, Watanabe M, Inoue N, et al. Association of the polymorphisms in the gene encoding thyroglobulin with the development and prognosis of autoimmune thyroid disease [J]. Autoimmunity, 2017, 50(6): 386-392. DOI: 10.1080/08916934.2017.1344971.
[8] Bossowski A, Czarnocka B, Stasiak-Barmuta A, et al. Analysis of Fas, FasL and Caspase-8 expression in thyroid gland in young patients with immune and non-immune thyroid diseases [J]. Endokrynol Pol, 2007, 58(4):303-313.
[9] Yang Q, Jeremiah Bell J, Bhandoola A. T-cell lineage determination [J]. Immunol Rev, 2010, 238(1):12-22. DOI: 10.1111/j.1600-065X.2010.00956.x.
[10] Druet P, Sheela R, Pelletier L. TH1 and TH2 lymphocytes in autoimmunity [J]. Adv Nephrol Necker Hosp, 1996, 25:217-241. DOI: 10.1111/j.1440-1797.1996.tb00091.x.
[11] Phenekos C, Vryonidou A, Gritzapis AD, et al. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2) [J]. Neuroimmunomodulation, 2004, 11(4): 209-213. DOI: 10.1159/000078438.
[12] Ben-Skowronek I, Szewczyk L, Kulik-Rechberger B, et al. The differences in T and B cell subsets in thyroid of children with Graves' disease and Hashimoto's thyroiditis [J]. World J Pediatr, 2013, 9(3): 245-250. DOI: 10.1007/s12519-013-0398-0.
[13] Nanba T, Watanabe M, Inoue N, et al. Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease [J]. Thyroid, 2009, 19(5):495-501. DOI: 10.1089/thy.2008.0423.
[14] Wilson NJ, Boniface K, Chan JR, et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells [J]. Nat Immunol, 2007, 8(9):950-957. DOI: 10.1038/ni1497.
[15] Li D, Cai W, Gu R, et al. Th17 cell plays a role in the pathogenesis of Hashimoto's thyroiditis in patients [J]. Clin Immunol, 2013, 149(3):411-420. DOI: 10.1016/j.clim.2013.10.001.
[16] Zake T, Skuja S, Kalere I, et al. Upregulated tissue expression of T helper (Th) 17 pathogenic interleukin (IL)-23 and IL-1β in Hashimoto's thyroiditis but not in Graves' disease [J]. Endocr J, 2019, 66(5):423-430. DOI: 10.1507/endocrj.EJ18-0396.
[17] Tanaka A, Sakaguchi S. Regulatory T cells in cancer immunotherapy [J]. Cell Res, 2017, 27(1):109-118. DOI: 10.1038/cr.2016.151.
[18] Sakaguchi S, Mikami N, Wing JB, et al. Regulatory T cells and human disease [J]. Annu Rev Immunol, 2020, 38:541-566. DOI: 10.1146/annurev-immunol-042718- 041717.
[19] Nakano A, Watanabe M, Iida T, et al. Apoptosis-induced decrease of intrathyroidal CD4(+)CD25(+) regulatory T cells in autoimmune thyroid diseases [J]. Thyroid, 2007, 17(1):25-31. DOI: 10.1089/thy.2006.0231.
[20] Chen Z, Wang Y, Ding X, et al. The proportion of peripheral blood Tregs among the CD4+ T cells of autoimmune thyroid disease patients: a meta-analysis [J]. Endocr J, 2020, 67(3):317-326. DOI: 10.1507/endocrj.EJ19-0307.
[21] Kondo M. Lymphoid and myeloid lineage commitment in multipotent hematopoietic progenitors [J]. Immunol Rev, 2010, 238(1):37-46. DOI: 10.1111/j.1600-065X. 2010.00963.x.
[22] Ramos-Leví AM, Marazuela M. Pathogenesis of thyroid autoimmune disease: the role of cellular mechanisms [J]. Endocrinol Nutr, 2016, 63(8):421-429. DOI: 10.1016/j.endonu.2016.04.003.
[23] Yu S, Qi Y, Wang H, et al. Dysfunction of CD24+CD38+ B cells in patients with Hashimoto's thyroiditis is associated with a lack of interleukin 10 [J]. Int J Biochem Cell Biol, 2017, 90:114-120. DOI: 10.1016/j.biocel.2017.08.002.
[24] Santaguida MG, Gatto I, Mangino G, et al. BREG cells in Hashimoto's thyroiditis isolated or associated to further organ-specific autoimmune diseases [J]. Clin Immunol, 2017, 184:42-47. DOI: 10.1016/j.clim.2017.04.012.
[25] Wu MY, Wang EJ, Feng D, et al. Pharmacological insights into autophagy modulation in autoimmune diseases [J]. Acta Pharm Sin B, 2021, 11(11): 3364-3378. DOI: 10.1016/j.apsb.2021.03.026.
[26] Kulig P, Musiol S, Freiberger SN, et al. IL-12 protects from psoriasiform skin inflammation [J]. Nat Commun, 2016, 7:13466. DOI: 10.1038/ncomms13466.
[27] Lubberts E. The IL-23-IL-17 axis in inflammatory arthritis [J]. Nat Rev Rheumatol, 2015, 11(7):415-29. DOI: 10.1038/nrrheum.2015.53.
[28] Lee Y, Awasthi A, Yosef N, et al. Induction and molecular signature of pathogenic TH17 cells [J]. Nat Immunol, 2012, 13(10):991-999. DOI: 10.1038/ni.2416.
[29] Zheng T, Xu C, Mao C, et al. Increased interleukin-23 in Hashimoto's thyroiditis disease induces autophagy suppression and reactive oxygen species accumulation [J]. Front Immunol, 2018, 9:96. DOI: 10.3389/fimmu.2018.00096.
[30] Xu C, Wu F, Mao C, et al. Excess iodine promotes apoptosis of thyroid follicular epithelial cells by inducing autophagy suppression and is associated with Hashimoto thyroiditis disease [J]. J Autoimmun, 2016, 75:50-57. DOI: 10.1016/j.jaut.2016.07.008.
[31] Senou M, Costa MJ, Massart C, et al. Role of caveolin-1 in thyroid phenotype, cell homeostasis, and hormone synthesis: in vivo study of caveolin-1 knockout mice [J]. Am J Physiol Endocrinol Metab, 2009, 297(2):E438-E451. DOI: 10.1152/ajpendo.90784.2008.
[32] Lu Q, Luo X, Mao C, et al. Caveolin-1 regulates autophagy activity in thyroid follicular cells and is involved in Hashimoto's thyroiditis disease [J]. Endocr J, 2018, 65(9):893-901. DOI: 10.1507/endocrj.EJ18-0003.
[33] Łacka K, Maciejewski A. The role of apoptosis in the etiopathogenesis of autoimmune thyroiditis [J]. Pol Merkur Lekarski, 2012, 32(188):87-92.

Research progress of Hashimoto's thyroiditis

桥本甲状腺炎的研究进展

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 11

Recommended Articles

Metrics

[1]	Wei Jingxun, Dong Binchang, Du Xin, Xu Huipu. Effect of Shexiang Baoxin Pills on angiogenesis in rabbits with acute myocardial infarction through SIRT1/mTOR signaling pathway [J]. International Medicine and Health Guidance News, 2023, 29(6): 801-807.
[2]	Chen Siqi, Peng Rongdong, Xu Jiaqi, Feng Junxia, Zhou Xiaoying, Zhang Yunfang, Su Yanyan. Selectively inhibiting Drp1 to attenuate renal injury induced by ischemia-reperfusion in rats [J]. International Medicine and Health Guidance News, 2023, 29(5): 663-669.
[3]	Wang Yimin, Li Qinghua. Advances in the relationships between small heat shock proteins and tumor apoptosis [J]. International Medicine and Health Guidance News, 2023, 29(3): 297-301.
[4]	Zhang Guijiang, Sun Bin. Application of laparoscopic ultrasound in laparoscopic resection of liver cancer and its influence on patients [J]. International Medicine and Health Guidance News, 2022, 28(9): 1277-1282.
[5]	Tong Lin, Li Wei, Gao Su, Li Weiwei, Yang Junli. Diagnostic value of soluble tumor necrosis factor-like apoptosis weak inducer for early neurological deterioration of acute cerebral infarction [J]. International Medicine and Health Guidance News, 2022, 28(21): 2974-2979.
[6]	Xiang Xiaohong, Hu Jingwei. Research advances in glucocorticoid-induced apoptosis [J]. International Medicine and Health Guidance News, 2022, 28(20): 2839-2843.
[7]	Chen Guiping, Li Min, Tian Zhihua, Shen Jianbo, Cui Jie, Duan Haifeng, Zhang Hao, Ru Xiaohong. Effects of ganglioside sodium combined with mild hypothermia on Fas/FasL signaling pathway and apoptosis of nerve cells in patients with severe craniocerebral injury [J]. International Medicine and Health Guidance News, 2022, 28(17): 2432-2437.
[8]	Li Xueying, Xu Yang, Wang Mi. Effect and mechanism of bisdesmethoxycurcumin on breast cancer in mice [J]. International Medicine and Health Guidance News, 2022, 28(16): 2311-2315.
[9]	Sui Hongmei, He Fengxi, Li Aihua, Li Aifeng, Wang Li, Lu Huanxi. Isolation and purification of flavonoid glycosides from Clinacanthus nutans (Burm.f.) Lindau and its antitumor effect on epithelial ovarian cancer [J]. International Medicine and Health Guidance News, 2022, 28(13): 1784-1789.
[10]	Zhang Lili, Sui Hongmei, He Fengxi, Liu Dandan, Li Aifeng, Li Aihua. Apoptosis of epithelial ovarian cancer cells induced by Emperum nrgrum var. Japorcum and its possible mechanism [J]. International Medicine and Health Guidance News, 2022, 28(13): 1789-1795.
[11]	Xiong Yanlin, Xie Lina, Qi Liuying. Chlorogenic acid inhibits apoptosis of human periodontal ligament cells in high glucose environment via AKT signaling pathway [J]. International Medicine and Health Guidance News, 2022, 28(1): 96-99.